Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,396 stories, page 64 of 807

Advanced search

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Beijing Beilu Pharmaceutical Co., Ltd. Class A Estimates – SZSE:300016

TradingViewOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Melanoma: the personalised vaccine works – a potential breakthrough in treatment (costs permitting)

Il Sole 24 OREOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Guangdong Jiaying Pharmaceutical Co., Ltd. Class A Estimates – SZSE:002198

TradingViewOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Triple-action weekly weight-loss drug reduces sleep apnea in two late-stage trials

Medical XpressOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Lilly’s sofetabart mipitecan shows 79% response rate in platinum-sensitive ovarian cancer

The Clinical Trial VanguardOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Perspective Therapeutics’ [212Pb]VMT-α-NET shows responses in neuroendocrine tumor trial

The Clinical Trial VanguardOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Sefaxersen Reduces Proteinuria 43% in Phase 3 IgA Nephropathy Study

The Clinical Trial VanguardOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

AmgenOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

US Treasury proposes expanding investment curbs on Chinese AI, biotech firms

ANI NewsOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Youcare Pharmaceutical Group Co. Ltd. Class A Estimates – SSE:688658

TradingViewOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

‘Practice-changing’ new lung cancer immunotherapy improves survival

NBC NewsOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

PR NewswireOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drug 2022

BusinessWorld OnlineOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Ascletis Pharma Inc. (1672.HK) stock price, news, quote and history

Yahoo Finance SingaporeOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Could lowering high blood pressure be as simple as stimulating your ear?

Science DailyOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

3 Australian Biotech Stocks To Own In October 2026

Yahoo FinanceOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Biotech stocks are surging. How investors can play the new drug innovation boom

CNBCOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

We asked analysts what's behind the massive gains in biotech stocks

CNBCOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Parabilis Medicines Reports 72.2% Objective Response Rate for Zolucatetide in Desmoid Tumors and Announces Phase 3 Development Plan

Quiver QuantitativeOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

What Is Drawing Attention To Legend Biotech (LEGN)?

Simply Wall StreetOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

The Maharashtra Food and Drug Administration (FDA) suspended Blinkit’s food business licence at its Bhiwandi facility over serious regulatory non-compliance. An October 21 inspection found that the company failed to provide end-to-end traceability records

InstagramOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

LelezardOriginal source

🇺🇸Oct 24Researchnejm.orgTier 2 · Direct publisher

The Future of Health Agency Enforcement Fines

NEJMOriginal source

🇺🇸Oct 24Researchnejm.orgTier 2 · Direct publisher

Abortion Care in Puerto Rico — A Fragile Legal Landscape

NEJMOriginal source

🇺🇸Oct 24Researchnejm.orgTier 2 · Direct publisher

My Father’s Code

NEJMOriginal source

🇺🇸Oct 24Researchnejm.orgTier 2 · Direct publisher

Thelaziasis

NEJMOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Executive pay raises boost performance at Chinese pharmaceutical firms, study finds

Bioengineer.orgOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

newly fda approved weight loss drug

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

Yahoo Finance UKOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda proposes restricting compounded alternatives for popular weight loss drugs

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approved over the counter weight loss drugs 2026

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approves diabetes drug for weight loss

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2026 latest

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Form PRE 14A PharmaCyte Biotech Inc For: 24 October By Investing.com

Investing.com AustraliaOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Stock Market News for Oct 23, 2026

Stock TitanOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

new weight-loss drug approved by the fda

BusinessWorld OnlineOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Form PRE 14A PharmaCyte Biotech Inc For: 24 October By Investing.com

Investing.com NigeriaOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

new fda drug approved for weight loss

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2026 latest

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Trump's China biotech rules leave investors guessing

AxiosOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Why Lotus Pharmaceutical Fell Even As Sales Rose

Yahoo FinanceOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp 1 drugs weight loss official

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026

The Manila TimesOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

An experimental lung cancer drug shrank tumors in 56% of patients whose tumors had high marker levels.

Stock TitanOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approved diabetes drug for weight loss

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

2017 fda approved weight loss drugs

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

FDA withdraws publication of COVID, shingles vaccine research findings

ABC News - Breaking News, Latest News and VideosOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approved over the counter weight loss drugs 2026

www.polskieradio.plOriginal source

🇨🇦Oct 24Industryir.zymeworks.comTier 1 · Company source

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

ZymeworksOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences Inc. (SGMT) Stock Price, News, Quote & History

Yahoo! Finance CanadaOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Upacicalcet Meets Primary Endpoints in Phase 3 Trials for Secondary Hyperparathyroidism

The Clinical Trial VanguardOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms

Yahoo FinanceOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

new fda approved diabetes drug for weight loss

ΕΜΥOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Ningbo Menovo Pharmaceutical Co., Ltd. Class A Estimates – SSE:603538

TradingViewOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Xizang Weixinkang Pharmaceutical Co., Ltd. Class A Estimates – SSE:603676

TradingViewOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

fda approves weight-loss drug zepbound for obstructive sleep apnea

www.polskieradio.plOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Health Brief: Making sense of Treasury’s biotech deal proposal

The Washington PostOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Shanghai Kaibao Pharmaceutical Co., Ltd. Class A Estimates – SZSE:300039

TradingViewOriginal source

🌍Oct 24discoverynews.google.comTier 2 · Trade media

US targets Chinese biotech investment, but licensing deals remain exempt

Pharmaceutical TechnologyOriginal source

🌍Oct 24discoverynews.google.comTier 3 · Aggregated media

Guiyang Xintian Pharmaceutical Co. Ltd. Class A Estimates – SZSE:002873

TradingViewOriginal source